Research Supplement to Promote Diversity: Carlos Torres (R03EB031495 Parent Award)
促进多样性的研究补充:Carlos Torres(R03EB031495 家长奖)
基本信息
- 批准号:10592146
- 负责人:
- 金额:$ 1.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntigensApplications GrantsAwardChildCommunicable DiseasesDevelopmentDoseDrug Delivery SystemsElectrospinningEncapsulatedEnrollmentEquipmentExhibitsFormulationGoalsHispanicIn VitroInjectionsInvestigationKineticsLabelMethodsModelingMorphologyNeedlesParentsPatientsPhysiologic pulsePolymersPopulationProcessProductionProteinsRegimenReporterReproducibilityResearchResource-limited settingResourcesRiskRural CommunityScienceStructureTechniquesTimeUninsuredVaccinationVaccinesWorkWorld Health Organizationaqueousbasecommunity collegecontrolled releasefight againsthealth care availabilityimprovedin vivolow and middle-income countriesmacromoleculemalenegative affectparent grantparticlepreventable deathtoolundergraduate studentvaccination schedule
项目摘要
PROJECT SUMMARY/ABSTRACT
Every year an estimated 19.4 million children do not receive the set of vaccines recommended by the World
Health Organization, leading to 1.5 million vaccine-preventable deaths.1,2 A majority of undervaccinated children
live in low- and middle-income countries and often have limited access to healthcare.2,3 Nearly 6 million of these
children receive at least one vaccine dose, but remain at risk because they have not completed the full dosing
regimen.4,5 A vaccination method that delivers all doses of a vaccine, or multiple vaccines, in a single injection
would enable children with even one-time access to healthcare to be fully protected from the corresponding
infectious disease. Unfortunately, most controlled-release drug delivery systems exhibit continuous release
kinetics, which is vastly different from traditional soluble vaccines administered in multiple discrete doses over a
course of months. One recent study has described the development of biodegradable microparticle platform with
a polymer shell encapsulating a vaccine-loaded core that exhibits delayed, pulsatile release after a period
determined by the polymer degradation rate.6 By injecting patients with a mixed population of particles with
different degradation rates, vaccine can be released as discrete pulses, thereby mimicking traditional vaccination
schedules known to be safe and effective. Unfortunately, the original microparticle production method negatively
affects antigen stability, requires the use of large-gauge needles, and is low-throughput. This project seeks to
overcome these challenges by preparing microparticles using coaxial electrospraying, a single-step fabrication
process that can produce a single aqueous, vaccine-loaded core surrounded by a shell of polymer. The parent
proposal first aims to create small core-shell microparticles with dense polymeric shells that demonstrate the
delayed, pulsatile release of macromolecules in vitro and in vivo using fluorescently-labeled model molecules
and reporter proteins to assess protein stability within the microparticles. This diversity supplement will expand
the scope of work previously proposed to support the work of Carlos Torres, a Hispanic male undergraduate
student at Houston Community College, including the investigation of coaxial electrospraying parameters
between pieces of electrospraying equipment. The goal of Carlos’s work is to identify the key features that affect
core-shell microparticle morphology and release kinetics and develop solutions that allows electrospraying
conditions to be readily transferred between different pieces of equipment. If successful, Carlos’s work will
enhance the reproducibility of science and allow different research groups to work in unison to improve
electrosprayed particle formulations for single-injection vaccination as well as other drug delivery applications.
Ultimately, these particles could serve as a key tool in the fight against infectious disease both in the developing
world where resources are limited and in the developed world, where uninsured children and rural communities
show consistently lower vaccination coverage.7
项目概要/摘要
每年估计有 1940 万儿童没有接种世界推荐的疫苗
卫生组织,导致 150 万人因疫苗可预防的死亡。1,2 大多数儿童未接种疫苗
生活在低收入和中等收入国家,获得医疗保健的机会往往有限。2,3 其中近 600 万人
儿童至少接受了一剂疫苗,但由于尚未完成全部剂量,因此仍面临风险
方案 4,5 在单次注射中提供所有剂量的疫苗或多种疫苗的疫苗接种方法
将使即使是一次性获得医疗保健的儿童也能得到充分保护,免受相应的影响
不幸的是,大多数控释药物递送系统表现出连续释放。
动力学,这与传统的可溶性疫苗在一段时间内以多个离散剂量施用有很大不同
最近的一项研究描述了可生物降解微粒平台的开发。
聚合物外壳封装了负载疫苗的核心,在一段时间后表现出延迟的脉冲释放
由聚合物降解率决定。6 通过向患者注射混合颗粒群
不同的降解率,疫苗可以作为离散脉冲释放,从而模仿传统的疫苗接种
不幸的是,原来的微粒生产方法被认为是安全有效的。
影响抗原稳定性,需要使用大规格针头,并且通量低。
通过使用同轴电喷雾(一步制造)制备微粒来克服这些挑战
该过程可以产生由聚合物外壳包围的单一水性、负载疫苗的核心。
该提案的第一个目标是创建具有致密聚合物壳的小核壳微粒,以证明
使用荧光标记的模型分子在体外和体内延迟、脉动释放大分子
和报告蛋白以评估微粒内的蛋白质稳定性。这种多样性补充将得到扩展。
先前提议支持西班牙裔男本科生卡洛斯·托雷斯 (Carlos Torres) 工作的工作范围
休斯顿社区学院的学生,包括同轴电喷雾参数的研究
卡洛斯的工作目标是确定影响电喷涂设备之间的关键特征。
核壳微粒形态和释放动力学,并开发允许电喷雾的解决方案
如果成功的话,卡洛斯的工作将能够在不同设备之间轻松转移。
提高科学的可重复性,并允许不同的研究小组协同工作以改进
用于单次注射疫苗接种以及其他药物输送应用的电喷雾颗粒制剂。
最终,这些颗粒可以成为发展中国家对抗传染病的关键工具。
资源有限的世界以及儿童和农村社区没有保险的发达国家
疫苗接种覆盖率持续较低。7
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Translating diagnostics and drug delivery technologies to low-resource settings.
- DOI:10.1126/scitranslmed.abm1732
- 发表时间:2022-10-12
- 期刊:
- 影响因子:17.1
- 作者:
- 通讯作者:
Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness.
- DOI:10.3390/bioengineering8110155
- 发表时间:2021-10-24
- 期刊:
- 影响因子:0
- 作者:Pogostin BH;McHugh KJ
- 通讯作者:McHugh KJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin James McHugh其他文献
Kevin James McHugh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin James McHugh', 18)}}的其他基金
Research Supplement to Promote Diversity: Belvi Bwela (R03EB031495 Parent Award)
促进多样性的研究补充:Belvi Bwela(R03EB031495 家长奖)
- 批准号:
10592142 - 财政年份:2022
- 资助金额:
$ 1.5万 - 项目类别:
Electrosprayed Core-Shell Microparticles as a Pulsatile Vaccine Delivery Platform
电喷雾核壳微粒作为脉冲疫苗输送平台
- 批准号:
10195135 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Solvent Evaporator Equipment Supplement to R35GM143101
R35GM143101 溶剂蒸发器设备补充
- 批准号:
10799251 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
用于控制药代动力学的下一代肠外给药系统
- 批准号:
10277139 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Electrosprayed Core-Shell Microparticles as a Pulsatile Vaccine Delivery Platform
电喷雾核壳微粒作为脉冲疫苗输送平台
- 批准号:
10372138 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
用于控制药代动力学的下一代肠外给药系统
- 批准号:
10890222 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Research Supplement to Promote Diversity: Mei-Li Laracuente (1R35GM143101 Parent Award)
促进多样性的研究补充:Mei-Li Laracuente(1R35GM143101家长奖)
- 批准号:
10631614 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
用于控制药代动力学的下一代肠外给药系统
- 批准号:
10667652 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Next-Generation Parenteral Drug Delivery Systems for Controlling Pharmacokinetics
用于控制药代动力学的下一代肠外给药系统
- 批准号:
10488240 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Biomaterial Strategies for Modulating the Immune Response
调节免疫反应的生物材料策略
- 批准号:
10232052 - 财政年份:2020
- 资助金额:
$ 1.5万 - 项目类别:
相似国自然基金
E3泛素连接酶MDM2对乙肝表面抗原组装和分泌的影响及机制研究
- 批准号:82300690
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
EGCG联合焦磷酸钠修饰小清蛋白抗原表位的降敏机理研究
- 批准号:22368024
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
乙肝病毒特异性受体NTCP的抗原识别结构基础和别构抑制剂筛选
- 批准号:32301001
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于蛋白特征序列模式广泛鉴定人基因组HERV元件env内源性超抗原的研究
- 批准号:32370663
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
牙鲆腹腔源MHCII和CD80/86阳性外泌体对抗原特异性免疫应答调控机制的研究
- 批准号:32373160
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Discovery and validation of biomarkers of autoimmunity in Alzheimer's Disease.
阿尔茨海默病自身免疫生物标志物的发现和验证。
- 批准号:
10589569 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别: